Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Dianthus Therapeutics, Inc. /DE/ has filed 652 SEC EDGAR filings since 23 Nov 2016

SEC filing history

Showing 251-275 of 652 matching filings.

Per page
25
Current page
11
SC 13D/A File 005-90538

SC 13D/A

Filing date
15 Sep 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
13 Sep 2023
Reporting date
11 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
13 Sep 2023
Reporting date
11 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Sep 2023
Reporting date
11 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
13 Sep 2023
Reporting date
11 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Sep 2023
Reporting date
11 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Sep 2023
Reporting date
11 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Sep 2023
Reporting date
11 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Sep 2023
Reporting date
11 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
13 Sep 2023
Reporting date
11 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Sep 2023
Reporting date
11 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Sep 2023
Reporting date
11 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Sep 2023
Reporting date
11 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Sep 2023
Reporting date
11 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Sep 2023
Reporting date
11 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Sep 2023
Reporting date
11 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Sep 2023
Reporting date
11 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Sep 2023
Reporting date
11 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
425 File 001-38541

425

Filing date
31 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-271917

EFFECT filing

Filing date
01 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-271917

424B3

Filing date
01 Aug 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
31 Jul 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .